Imagion Biosystems Ltd (PK) (IBXXF) Cotización

IBXXF one for 40 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

This is shaping up to be a classic.

Way over 1 billion shares outstanding.

Pitiful performance regarding the first in human trial.

Which will happen first, more fund raising (dilution) or reverse split?

Either way, current shareholders getting smacked with the reality of investing too soon and getting wiped out long before any meaningful progress is made.

I see ibx annual report has been released. All in all, the company seems to be moving along much better than it did under manny and marv's greedy, self-serving control.

The sad fact for shareholders is what seems like a brick wall at the ipo price of .20 - between all the dilution(now over 1 billion o/s), and all those who are happy to get back to break even and get out.

Once all the sellers at .20 are done, the big question will be can ibx produce positive news and progress faster than it dilutes. There is $13 million or so in cash on hand, but these trials and product development costs are quite expensive.

What is the difference between IBXXF and IBX:AU?

You will be able to fund Fidelity faster with a direct bank deposit than a transfer from another account.

Fidelity.com was recommended to me by Rusty. As it is a low stock price, you will have to go through the international trading office. You will have to set up an account on line first, fund it - which take 3-4 days, then call the international trading office at 1-800-544-2976. You will not be able to make this trade on line due to the price of the stock. They will give you the exchange rate for the Australian dollar, what’re that happens to be at the time of the trade. It was app $1 US to $1.35 Australian.

I was able to pick up some shares through TD Ameritrade, however you I believe you pay a premium as there are not many shares moving on that exchange. IBX in the US is IBXXF through TD AMERITRADE. Through Fidelity you can buy it as IBXXF with US dollar or IBX:AU with the exchange rate. I am not familiar with the exchange rate process, however there are many more shares of IBX moving on the Australian market then with TD Ameritrade.

Fidelity will charge you a commission and a exchange rate fee, which will run a little over $100 for 30,000 shares, perhaps $150 for 50,000 shares. Fidelity will give you an idea of this cost before you place the order.

New here. Does anyone use a U.S. broker to trade ibx? which one & how much are commissions? Thanks. This looks like a good one.

More dilution. $6M raised, to issue 78M shares. The only redeeming feature is Institutional investors have jumped in here.

I distinctly remember Bobby boy telling all of us that there would be no further dilution or was I dreaming it. LOL

Cheers mates.

A nice documentary about IBX here...

Almost 1 billion outstanding shares. Does anyone know how many shares are authorized? I don't know where to find this for an Australian company.

What is the date of that presentation? It says about 500 million shares o/s, but current info says over 900 million. Is that correct? Has the number of o/s almost doubled just this year? And the study hasn't even begun yet. More cash needed (again)? Could that be why shares have turned down again?

Looks like interesting technology, but still much too early to buy in and not suffer the pain of additional dilution imo.

ibx shares sinking again. Is it true the phase I trial (which doesn't even include a human version of the magsense instrument) hasn't been approved to begin yet?

I use Fidelity to trade from the US. In my account listed as IBX:AU. Now it looks like you can purchase on pink sheets though as IBXXF. When did that start?

Not sure why all this sudden surge in the stock price, but I won't complain.

Mind you, IPO was at 20 cents so clawing back to 1/2 that price is still not enough for me.

Wake me up at 30 cents.

hooroo and good luck mates

Here it is from the outback.

https://www.asx.com.au/asxpdf/20200728/pdf/44kx0spyvct1zg.pdf

Seems like more dilution coming. when will it end?

I used to think Bobby Proulx knew what he was doing. So many truths that are only half-truths.

All I want is the whole truth, tell us there is no human instrument coming any time soon. Why not just say it?

Two trading halts in a row, why would you do that?

I was looking for a brokerage a U.S. citizen would use to trade ibx without dealing with the tax implications of having a foreign account.

yes, why?

Do you live in Australia?

Westpac.

Pricy but worth the money and they provide extensive research.

What broker do you use to trade ibx?

Imagion establishes collaboration with Siemens Healthineers.

https://www.asx.com.au/asxpdf/20200520/pdf/44hz39wnbdxj6n.pdf

Better than .0005?
But...Oil is Gold..doncha think my friend?

GO ERHC________

Everything Proulx has done lately just stinks. Nothing more to say or write about.

The dilution is simply out of this world. No way for me to get out other than sell at a heavy loss. So, now in it for as long as I can stand his paid PR/IR pieces and those are becoming more vomiting exercises in propaganda.

I won't be posting anything unless it is real and solid, and does not include fluff and paid content.

Extremely frustrated shareholder!!!

See why Proulx always looks so happy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154806310

Anything for a few tenths of a cent.

Possible detection of Covid virus being talked about -

Seeing the investment opportunity in medical imaging...

"Imagion Biotech’s focus on diagnostic imaging addresses a $2 billion worldwide market. Adding therapeutic utility would expand the revenue opportunity for the company in the cancer therapy industry — a market reported to be worth as much as $136 billion".

"Already, Israeli researchers have picked up on MagSense’s potential for cancer treatment and bought patents on the company’s nanoparticles. These will be used in hypothermia treatments to kill cancer cells".

A brief message of IBX in the video on medical imaging...

https://themarketherald.com.au/seeing-the-investment-opportunity-in-medical-imaging-2020-03-11/?__hstc=51568950.4fbcf9489505e38a31f9d641b1ad5b05.1578440267139.1583898631893.1583968596026.154&__hssc=51568950.2.1583968596026&__hsfp=2108780635

Rusty, You may be correct on the timing of the study, but read my response to ssc on the mhtx board.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154128873

It is the only logical step for IBX. Use the money you have wisely. I highly doubt that the first study will use a human instrument from Planet Innovations. Just MHO here.

It looks like the First in Human, (FIH), studies will start either in July or August according to their recent Progress Report list. The clinical design plan is complete by Planet Innovations as well. They have already started the instrument production, (since the development stage is now complete), and the mass making of Commercial Formulation Production will begin before the end of this year....

https://www.asx.com.au/asxpdf/20200302/pdf/44fnb2x0tsbbmf.pdf

Good news, but it still seems that they have a long way to go to the human study. "later this year" seems like a far away place that seems to always be delayed.

Business Update: Manufacturing Commences

Imagion Biosystems Limited (ASX: IBX) (the Company), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to provide an update on progress towards its key business objective of initiating its first study for HER2 metastatic breast cancer in human subjects this year.

The primary operational focus for the past quarter has been on ensuring the readiness of its contract-manufacturing partners to begin the manufacturing of the nanoparticle formulation to be used in the study. The company is pleased to report it has purchased equipment and supplies and has completed the necessary vendor qualifications and audits to confirm compliance with GMP (Good Manufacturing Practice), required for the manufacturing of medical devices and pharmaceutical products used in human clinical studies.

With these steps complete, the company will now commence manufacturing.

“Patient safety is of paramount importance for all human studies,” said Bob Proulx, Executive Chairman of Imagion Biosystems. “With this being the first time our nanoparticle product is to be used in a human study, we have taken great care in our preparations to ensure we could move forward with confidence into manufacturing and achieve the exacting standards required of GMP manufacturing processes.”

While manufacturing proceeds, the Company will continue working on the other key areas needed to support initiating the study later this year when manufacturing is complete. This includes establishing clinical sites and preparing the sites for enrolment of subjects, and receiving the necessary regulatory authorization, for example an Investigational Device Exemption (IDE) from the US FDA.

Dialogue with the FDA continues as previously advised, and is in line with expectations at this stage of the process.

This may be of interest here. Still waiting on Imagion to explain it all.

Kemper Shaw is on the BOD at Californian based company Collinear, Wireless Connectivity Innovator:-
https://www.collinear.com/leadership/"

Now the curious thing is that the last time we had a massive selldown like this, it was done by his mate, William Taylor, who offloaded about 20 million shares. These guys both worked together at Collinear...

This link details when they both became significant SHs and now both have offloaded in a big way killing the momentum of the SP rally once again......why????

https://www.biotechdaily.com.au/media/backissues/2019/01%20Jan/BD%20Biotech%20Daily%20Jan%2031.pdf

"IMAGION BIOSYSTEMS

In separate filings, Kemper Shaw and William Taylor Nominees say both have become substantial shareholders in Imagion with 36,798,818 shares (11.4%). Both Mr Shaw and William Taylor Nominees’ James and Marion Taylor gave the same Bondi Junction post box address, said they each acquired 25,000,000 shares in the rights issue that raised $4.3 million at four cents a share and held the same number of shares (BD: Nov 19, 2018).

A spokesman for Imagion told Biotech Daily that the two identical holdings were held by Kemper Shaw and James Taylor, who both worked for the same company. Imagion fell 0.4 cents or 10.8 percent to 3.3 cents."

They both purchased the exact same number of shares, 36,798,818

Anyway, good news in that it was only the one person that caused all of that chaos yesterday; why did he bail, who knows?? What kind of negative inside info would he have when the trials haven't started?? Why did his mate William Taylor bail when he did back in July, each to their own.

Now I did a bit more digging and have found that these guys are locked in a court case with Lockheed Martin, the massive aerospace company. Lockheed Martin is suing Collinear. These court proceedings started in July, the same time Taylor sold down, and I believe it's still in progress; refer to these links:-

https://dockets.justia.com/docket/california/candce/5:2019cv04074/344870
(you'll find William Taylor and Kemper Shaw mentioned in this article)

https://casetext.com/case/lockheed-martin-corp-v-aceworld-holdings-pty-ltd

Maybe Shaw and Taylor need the cash??

It also appears as if William Taylor Nominees, another large shareholder may be selling.

Perhaps, but it was more the fact that one of the largest shareholders sold.Kemper Shaw

https://www.asx.com.au/asxpdf/20200214/pdf/44f3dq4h6ffvrn.pdf

Not a good sign when one of your largest shareholders sells on zero news.

All that volume and price back to 3 cents. People understand how much more dilution will be required.

Didn't anyone else notice that IBX trade over 57M shares yesterday?

Not sure what to make of it, other than there were huge sellers.

Huge volumes like this should follow some kind of news. Something fishy?? or insiders jumping ship before news?

Once again IBX is silent. Trading over 10% of your MC needs an explanation from Bob Proulx, even if it's just "nothing new, just market fluctuations".

Wake up IBX, tell your shareholders something.

THX for your DD rusty !

i found a new IBX websight is being developed tonight with much more info being put onto it. They are still in the process of designing it though.....

Old sight... https://imagionbiosystems.com/

New sight... https://imagion-biosystems.adrianbeyerle.com/#

THX Rusty !

Sorry for over 3 months back. I'll try locating more recent info next time...LOL

Moving along - Need some new press info.

"Superparamagnetic relaxometry (SPMR) exploits the unique magnetic properties of targeted superparamagnetic iron oxide nanoparticles (SPIOs) to detect small numbers of cancer cells".

https://www.ncbi.nlm.nih.gov/pubmed?db=PubMed&cmd=search&term=31422952

I'd guess a reverse split is in the future.

Talk, hype, talk, hype, and on and on it goes. Your question is on the money. 2 cent offering 2 cent stock.

The dilution is a killer and IBXR is trading at 1 cent. Pitiful

Seems like the more Proulx talks, the lower ibx falls. Bid now under 2 cents. Could investors be reading between his lines and seeing how much more time and money ie dilution will be required?

Don't you just love negative news ?
Welcome to penny land !.

Now $.027, tracking the fall of ntek.

A detailed analysis just by looking at a price chart. Now down to $.037 from $.20 - are you sure this isn't related to ntek?

All these interviews and updates and ibx still struggling to stay above 4 cents. Not surprisingly there is no mention about the status of the design and development of the human device or how much additional dilution is coming. But the market is sending its own message and its not a good one.

Imagion Biosystems investor update

https://www.asx.com.au/asxpdf/20191002/pdf/44941z2dxksbf0.pdf